Brensocatib

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameBrensocatib
Drug Alias NameBrinsupriINS-1007AZD-7986
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin C inhibitors
TargetsCathepsin C
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Renal InsufficiencyLung Diseases +[8] 
Global Approved IndicationsLung DiseasesBronchiectasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/08/12
Country/TerritoryCzechiaBelgiumBulgaria +[38] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesInsmed Netherlands BvInsmed Inc
Inactive CompaniesAstrazeneca PlcUniversity Of Dundee
Active IndicationsRenal InsufficiencyLung DiseasesBronchiectasis +[7] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A